A carregar...
Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy
Translationally controlled tumor protein (TCTP) represents an exquisite target for cancer differentiation therapy, because it was most strikingly down-regulated in tumor reversion experiments. Since TCTP is identical with the histamine releasing factor, antihistamic drugs may inhibit TCTP. Indeed, a...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4941353/ https://ncbi.nlm.nih.gov/pubmed/26921194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7605 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|